Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) treatment, today announced the first-in-human results of the Reprieve System at the CSI Focus D-HF ...
Background: Acute myeloid leukemia (AML ... which provided new ideas and potential targets for personalized treatment of AML. The studies involving humans were approved by Clinical Trial Ethics ...